Machine learning finds rate of change—not value of ovarian cancer biomarker—indicates recurrence

Julius Bogdan, vice president and general manager of the Healthcare Information and Management Systems Society (HIMSS) Digital Health Advisory Team for North America, explains the use of artificial intelligence (AI) algorithms to help address health disparities and the rise of healthcare consumerism. Machine Learning

Researchers utilized a machine learning algorithm to determine that a higher rate of change—rather than actual value of cancer antigen 125 (CA125)—is associated with abdominal recurrence of ovarian cancer. Findings may help identify patients most likely to benefit from imaging surveillance of the disease.

Diamonds may be a sparkling method to reduce costs of medical imaging, drug studies

screen_shot_2018-05-21_at_10.19.59_am.png

Microscopic images of diamond particles with nitrogen-vacancy defects. Courtesy of UC Berkeley. 

A new discovery involving diamonds may significantly cut costs related to medical imaging and drug-discovery devices, according to a team of researchers led by the U.S. Department of Energy and the University of California, Berkeley.